Comparison of methods for calculating the health costs of endocrine disrupters: a case study on triclosan

Table 3 The attributable fraction for obesity

Percentiles		P0–9	P10–24	P25–49	P50–74	P75–89	P90+
Concentration of TCS (ng/mL)		0	0	0	31.21	112.40	186.32
Increase of BMI points		0	0	0	1.04	0.26	0.26
Prevalence obesity %	Women	0	0	0	5.72	1.37	1.37
	Men	0	0	0	6.25	1.52	1.52
Direct health costs per case	€ 811
Total number of cases	7,199,228
Total direct health costs	€ 5,838,573,648
Sensitivity analysis
Total number of cases	7,199,228
Total direct health costs	€ 5,838,573,648

ISSN: 1476-069X